Leiomyosarcoma (LMS) Active Not Recruiting Phase 2 Trials for Pembrolizumab (DB09037)

Back to Leiomyosarcoma (LMS)

Also known as: LMS - Leiomyosarcoma / Leiomyosarcomas / Leiomyosarcoma / Leiomyosarcoma (morphologic abnormality) / Leiomyosarcoma NOS / Leiomyosarcoma (disorder)

IndicationStatusPhase
DBCOND0118909 (Leiomyosarcoma (LMS))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03899805
A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue SarcomasTreatment